Get the Stockscreener App
8.94
8.50%
0.70
After Hours:
8.91
-0.03
-0.34%
Corvus Pharmaceuticals Inc Stock (CRVS) Forecast
The Corvus Pharmaceuticals Inc (CRVS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.3121, representing a -85.32% decrease from the current price of $8.94. The highest analyst price target is $2.4067, and the lowest is $0.2175.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRVS Price Target
Average 2.3384
(-73.84% Downside)
Is Corvus Pharmaceuticals Inc (CRVS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 60.34 | Neutral |
| STOCH(9,6) | 29.08 | Neutral |
| STOCHRSI(14) | 28.99 | Neutral |
| MACD(12,26) | 0.3877 | Sell |
| ADX(14) | 26.14 | Buy |
| William %R | -47.75 | Neutral |
| CCI(14) | -21.86 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.72
Buy
|
8.607
Buy
|
| MA20 |
8.7805
Buy
|
8.4223
Buy
|
| MA50 |
7.1412
Buy
|
7.2779
Buy
|
| MA100 |
5.185
Buy
|
5.8329
Buy
|
| MA200 |
3.5639
Buy
|
4.3863
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, CRVS could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on CRVS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 60.34 indicates that CRVS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 29.08 indicates that CRVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.99 indicates that CRVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.14 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -21.86 indicates that CRVS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CRVS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Corvus Pharmaceuticals Inc financial reports and earnings history, Corvus Pharmaceuticals Inc (CRVS) stock could reach $1.236 by 2030, $2.809 by 2040 and $6.7522 by 2050. See the projected annual prices until 2050 of the Corvus Pharmaceuticals Inc stock below:
- Corvus Pharmaceuticals Inc (CRVS) is expected to reach an average price of $0.8253 in 2035, with a high prediction of $1.1785 and a low estimate of $0.9469. This indicates an $-90.77% rise from the last recorded price of $8.94.
- Corvus Pharmaceuticals Inc (CRVS) stock is projected to chart a bullish course in 2040, with an average price target of $2.8991, representing an $-67.57% surge from its current level. The forecast ranges from a conservative $2.9853 to a sky-high $2.809.
- Our analysts predict Corvus Pharmaceuticals Inc (CRVS) to jump -43.19% by 2045, soaring from $5.1933 to an average price of $5.0792, potentially reaching $5.1958. While $5.1933 is the low estimate, the potential upside is significant.
- Corvus Pharmaceuticals Inc (CRVS) stock is expected to climb by 2050, reaching an average of $6.6551, a $-25.56% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.7522 and $6.7461, respectively, highlighting the market's uncertainty.
Corvus Pharmaceuticals Inc Stock (CRVS) Year by Year Forecast
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2024
Our forecast for CRVS stock price in 2024 now indicates an average price target of $2.5338 with a high forecast of $4.9632 and a low forecast of $0.1043. The average prediction reflects an decrease of -71.66% from the last recorded price of $8.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $2.1924 | $0.2175 | $2.4067 | -75.48% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2025
Corvus Pharmaceuticals Inc Stock (CRVS) is expected to reach an average price of $2.3384 in 2025, with a high prediction of $4.6674 and a low estimate of $0.00937. This indicates an -73.84% fall from the last recorded price of $8.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.4299 | $0.8937 | $3.2053 | -72.82% |
| February, 2025 | $3.0069 | $2.0404 | $3.9915 | -66.37% |
| March, 2025 | $1.0236 | $0.7686 | $3.6423 | -88.55% |
| April, 2025 | $0.1944 | $0.00937 | $1.544 | -97.83% |
| May, 2025 | $0.1372 | $0.1172 | $0.3222 | -98.47% |
| June, 2025 | $1.2488 | $0.0476 | $1.9644 | -86.03% |
| July, 2025 | $0.7387 | $0.6104 | $1.9496 | -91.74% |
| August, 2025 | $2.1874 | $0.292 | $4.6674 | -75.53% |
| September, 2025 | $2.0591 | $1.2928 | $2.9882 | -76.97% |
| October, 2025 | $0.9461 | $0.7861 | $2.1045 | -89.42% |
| November, 2025 | $1.8677 | $0.8519 | $2.7569 | -79.11% |
| December, 2025 | $1.8447 | $1.6539 | $3.6085 | -79.37% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2026
The predicted value for Corvus Pharmaceuticals Inc (CRVS) in 2026 is set at an average of $3.8562. Estimates vary from a peak of $7.7003 to a trough of $0.0121, indicating an -56.87% surge from the present price of $8.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.9363 | $1.7101 | $2.1964 | -78.34% |
| February, 2026 | $1.9279 | $1.5625 | $2.3325 | -78.43% |
| March, 2026 | $2.0095 | $1.4587 | $2.3795 | -77.52% |
| April, 2026 | $1.7366 | $1.4366 | $3.0512 | -80.58% |
| May, 2026 | $1.0682 | $0.5374 | $2.562 | -88.05% |
| June, 2026 | $0.9198 | $0.8161 | $1.3036 | -89.71% |
| July, 2026 | $0.5468 | $0.4968 | $1.1614 | -93.88% |
| August, 2026 | $0.8684 | $0.4622 | $0.9684 | -90.29% |
| September, 2026 | $0.6554 | $0.5654 | $0.9438 | -92.67% |
| October, 2026 | $0.2471 | $0.0771 | $0.6708 | -97.24% |
| November, 2026 | $0.3987 | $0.0121 | $0.4687 | -95.54% |
| December, 2026 | $3.0157 | $0.3649 | $7.7003 | -66.27% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Corvus Pharmaceuticals Inc (CRVS) is $1.8474, with a high forecast of $3.6819 and a low forecast of $0.013. This indicates an -79.34% decrease from the last price of $8.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.6623 | $2.4673 | $3.6819 | -70.22% |
| February, 2027 | $1.7089 | $1.4789 | $3.4581 | -80.88% |
| March, 2027 | $0.9659 | $0.8059 | $1.8651 | -89.20% |
| April, 2027 | $0.5075 | $0.3075 | $1.0413 | -94.32% |
| May, 2027 | $0.1092 | $0.013 | $0.513 | -98.78% |
| June, 2027 | $0.1638 | $0.0508 | $0.4546 | -98.17% |
| July, 2027 | $0.0322 | $0.0476 | $0.1695 | -99.64% |
| August, 2027 | $0.2606 | $0.0468 | $0.4486 | -97.09% |
| September, 2027 | $0.5436 | $0.3652 | $0.5436 | -93.92% |
| October, 2027 | $0.552 | $0.5882 | $0.5328 | -93.83% |
| November, 2027 | $0.4103 | $0.5857 | $0.5268 | -95.41% |
| December, 2027 | $0.5233 | $0.6049 | $0.5787 | -94.15% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2028
In 2028, Corvus Pharmaceuticals Inc (CRVS) is projected to reach an average price of $1.5185, with a high projection of $2.9014 and a low estimate of $0.1356. This indicates an -83.01% fall from the last price of $8.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6237 | $0.5579 | $0.5751 | -93.02% |
| February, 2028 | $0.6916 | $0.6263 | $0.6655 | -92.26% |
| March, 2028 | $0.6161 | $0.6231 | $0.5931 | -93.11% |
| April, 2028 | $0.5667 | $0.6132 | $0.5863 | -93.66% |
| May, 2028 | $0.6002 | $0.4751 | $0.5645 | -93.29% |
| June, 2028 | $0.539 | $0.5782 | $0.5566 | -93.97% |
| July, 2028 | $0.5911 | $0.5912 | $0.5737 | -93.39% |
| August, 2028 | $0.7142 | $0.6304 | $0.6196 | -92.01% |
| September, 2028 | $0.2626 | $0.6226 | $0.6183 | -97.06% |
| October, 2028 | $0.121 | $0.321 | $0.1563 | -98.65% |
| November, 2028 | $1.906 | $0.1356 | $2.3898 | -78.68% |
| December, 2028 | $1.0177 | $0.6777 | $2.9014 | -88.62% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2029
The 2029 price forecast for Corvus Pharmaceuticals Inc Stock (CRVS) is $0.9567 on average, with a high prediction of $1.8985 and a low estimate of $0.0149. This represents an -89.30% decrease from the previous price of $8.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.0047 | $0.8793 | $1.8985 | -88.76% |
| February, 2029 | $0.8463 | $0.7609 | $1.2063 | -90.53% |
| March, 2029 | $0.3779 | $0.3125 | $1.2117 | -95.77% |
| April, 2029 | $0.2195 | $0.1541 | $0.4133 | -97.54% |
| May, 2029 | $0.2365 | $0.0149 | $0.6265 | -97.35% |
| June, 2029 | $0.4781 | $0.0819 | $0.4981 | -94.65% |
| July, 2029 | $0.6498 | $0.299 | $0.7936 | -92.73% |
| August, 2029 | $0.9168 | $0.5452 | $1.3206 | -89.75% |
| September, 2029 | $1.2884 | $0.8676 | $1.5076 | -85.59% |
| October, 2029 | $0.7554 | $0.6754 | $1.394 | -91.55% |
| November, 2029 | $0.387 | $0.287 | $0.914 | -95.67% |
| December, 2029 | $0.97 | $0.3824 | $0.86 | -89.15% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2030
Corvus Pharmaceuticals Inc Stock (CRVS) is expected to reach an average price of $1.2186 in 2030, with a high forecast of $2.4265 and a low forecast of $0.0107. This signifies an -86.37% decrease from the last price of $8.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.721 | $1.1492 | $1.236 | -80.75% |
| February, 2030 | $0.4673 | $0.1273 | $2.4265 | -94.77% |
| March, 2030 | $1.2371 | $0.1581 | $1.1481 | -86.16% |
| April, 2030 | $1.5413 | $1.1579 | $1.2363 | -82.76% |
| May, 2030 | $1.8972 | $1.3147 | $1.7122 | -78.78% |
| June, 2030 | $1.659 | $1.669 | $1.8814 | -81.44% |
| July, 2030 | $1.825 | $1.4066 | $1.795 | -79.59% |
| August, 2030 | $0.5618 | $1.3818 | $1.5642 | -93.72% |
| September, 2030 | $0.4015 | $0.0107 | $0.8307 | -95.51% |
| October, 2030 | $0.2295 | $0.0197 | $1.6331 | -97.43% |
| November, 2030 | $2.2112 | $0.5787 | $1.2413 | -75.27% |
| December, 2030 | $2.603 | $2.6088 | $2.288 | -70.88% |
0.93%
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):